Gary Swan has been appointed vice president of operations, Laureate Pharma, Inc. In this newly created position, Mr. Swan will be responsible for leading the company’s manufacturing operations, which include upstream and downstream processing, formulation and filling, facilities maintenance, warehouse operations, and environmental health and safety regulations.
   
“We are delighted to welcome Gary to Laureate’s senior leadership team,” said Robert J. Broeze, Ph.D., president and chief executive officer of Laureate. “With his strong background and extensive experience of more than 30 years in biopharmaceutical manufacturing operations, Gary will play a key leadership role in driving and managing Laureate’s tremendous growth.”
   
Mr. Swan’s experience includes biopharmaceutical manufacturing, engineering, technical services, validation, and quality control. Most recently, he served as senior director of manufacturing at Nastech Pharmaceuticals, a biopharmaceutical company developing products based on molecular biology-based drug delivery technologies. At Nastech, Mr. Swan directed the operations at two manufacturing sites in New York and Washington and led the planning and production of R&D, clinical, and licensed products. Prior to Nastech, he was the vice president of operations at VI Technologies, where he was responsible for strategic planning and daily operation of a sterile product facility with a staff of 200.